AUTHORS

Real Money authors - Mark Abssy

Mark Abssy

Mark Abssy is the Head of Indexing at Tematica Research focused on index and ETP development. He has product development/management experience with ETFs, ETNs, closed-end funds, mutual funds, listed derivatives and has been directly involved in the development of a number of innovative investment products across multiple issuers including FAN, HACK, SKYY, YYY, IPAY, ISRA, GAMR, CNCR, JGLD, DTOX in the US and ISPY, FOOD, CYBR, DIGI and DTOX in Europe. In his 25 year career he has held product development and management positions at NYSE|ICE, ISE ETF Ventures, Morgan Stanley, Fidelity Investments and Loomis Sayles.  He received a BSBA from Northeastern University with a focus in Finance and International Business.
Email Mark Abssy

Recent Articles By The Author

This Under-the-Radar Fund Is Giving the SPY a Run for Its Money

The Invesco S&P Spin-Off exchange-traded fund is holding its own against the SPDR S&P 500 ETF Trust. Can it keep it up?

It's Tough to Beat the S&P, but This Fund Makes a Good Fight

Let's see how the Invesco Buyback Achievers exchange-traded fund takes a passive approach that can pay off.

You Want to Invest in Canada? Then Check Out This ETF, Eh?

This exchange-traded fund focused on Canadian equities has outperformed the SPDR S&P 500 ETF by a nice margin this year.

Sorting Through Exchange-Traded Products, We Find a Carbon Credit Play

Let's look at what an ETN is and then get into a type of ETN that has been working for investors so far this year.

Welcome to 'Dimension X': Two More Mutual Funds Beam Up into ETFs

It started with asset manager Dimension, and now One Capital Management is aiming Fund X to the exchange-traded fund arena.

This New ETF's Novel Offering? Leveraged Returns on Individual Stocks

Leveraged ETFs are old news but these funds from AXS Investments break new ground.

2 New ETFs That Give Even the Little Guy Some Rate and Inflation Protection

These exchange-traded funds from Global X offer small investors investment options that once were available only to fat cats.

SARK Investors Lark It Up at ARKK's Expense, but for How Long?

The Tuttle Capital Short Innovation exchange-traded fund has been outperforming just about everything lately -- here's how and what to consider before you jump aboard.

This ETF Surged While Everyone Else Struggled. How Did It Do It?

The AGFiQ U.S. Market Neutral Anti-Beta Fund managed to return 18.50% over the past quarter -- and, no, it's not an inverse or levered inverse fund.

This ETF Boasts 'Inflation Protection,' but Will It Rise to the Occasion?

The Ionic Inflation Protection exchange-traded fund, the latest such ETF to hit the market, offers direct exposure to the consumer price index.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight